Dihydrolipoyl transacetylase

Dihydrolipoyl transacetylase
dihydrolipoyllysine-residue acetyltransferase
Asymmetric unit.jpg
Atomic structure of a single subunit of dihydrolipoyl transacetylase from Azotobacter vinelandii that makes up the structural core of the pyruvate dehydrogenase multienzyme complex.[1]
Identifiers
EC number 2.3.1.12
CAS number 9032-29-5
Databases
IntEnz IntEnz view
BRENDA BRENDA entry
ExPASy NiceZyme view
KEGG KEGG entry
MetaCyc metabolic pathway
PRIAM profile
PDB structures RCSB PDB PDBe PDBsum
Gene Ontology AmiGO / EGO
dihydrolipoamide S-acetyltransferase

Crystal structure of pyruvate dehydrogenase kinase 3 bound to lipoyl domain 2 of human pyruvate dehydrogenase complex.[2]
Identifiers
Symbols DLAT; PDCE2; DLTA
External IDs OMIM608770 MGI2385311 HomoloGene6814 GeneCards: DLAT Gene
EC number 2.3.1.12
Orthologs
Species Human Mouse
Entrez 1737 235339
Ensembl ENSG00000150768 ENSMUSG00000000168
UniProt P10515 Q8BMF4
RefSeq (mRNA) NM_001931 NM_145614
RefSeq (protein) NP_001922 NP_663589
Location (UCSC) Chr 11:
111.4 – 111.44 Mb
Chr 9:
50.44 – 50.47 Mb
PubMed search [1] [2]


Dihydrolipoyl transacetylase (or dihydrolipoamide acetyltransferase) is an enzyme component of the multienzyme pyruvate dehydrogenase complex. The pyruvate dehydrogenase complex is responsible for the pyruvate decarboxylation step that links glycolysis to the citric acid cycle. This involves the transformation of pyruvate from glycolysis into acetyl-CoA which is then used in the citric acid cycle to carry out cellular respiration.

There are three different enzyme components in the pyruvate dehydrogenase complex. Pyruvate dehydrogenase (EC 1.2.4.1) is responsible for the oxidation of pyruvate, dihydrolipoyl transacetylase (this enzyme; EC 2.3.1.12) transfers the acetyl group to coenzyme A (CoA), and dihydrolipoyl dehydrogenase (EC 1.8.1.4) regenerates the lipoamide. Because dihydrolipoyl transacetylase is the second of the three enzyme components participating in the reaction mechanism for conversion of pyruvate into acetyl CoA, it is sometimes referred to as E2.

In humans, dihydrolipoyl transacetylase enzymatic activity resides in the pyruvate dehydrogenase complex component E2 (PDCE2) that is encoded by the DLAT (dihydrolipoamide S-acetyltransferase) gene.[3]

Contents

Nomenclature

The systematic name of this enzyme class is acetyl-CoA:enzyme N6-(dihydrolipoyl)lysine S-acetyltransferase.

Other names in common use include:

  • acetyl-CoA:dihydrolipoamide S-acetyltransferase,
  • acetyl-CoA:enzyme 6-N-(dihydrolipoyl)lysine S-acetyltransferase.
  • dihydrolipoamide S-acetyltransferase,
  • dihydrolipoate acetyltransferase,
  • dihydrolipoic transacetylase,
  • dihydrolipoyl acetyltransferase,
  • enzyme-dihydrolipoyllysine:acetyl-CoA S-acetyltransferase,
  • lipoate acetyltransferase,
  • lipoate transacetylase,
  • lipoic acetyltransferase,
  • lipoic acid acetyltransferase,
  • lipoic transacetylase,
  • lipoylacetyltransferase,
  • thioltransacetylase A, and
  • transacetylase X.

Structure

All dihydrolipoyl transacetylases have a unique multidomain structure consisting of (from N to C): 3 lipoyl domains, an interaction domain, and the catalytic domain (see the domain architecture at Pfam). Interestingly all the domains are connected by disordered, low complexity linker regions.

Depending on the species, multiple subunits of dihydrolipoyl transacetylase enzymes can arrange together into either a cubic or dodecahedral shape. These structure then form the catalytic core of the pyruvate dehydrogenase complex which not only catalyzes the reaction that transfers an acetyl group to CoA, but also performs a crucial structural role in creating the architecture of the overall complex.[4]

The cubic catalytic core structure made up of 24 dihydrolipoyl transacetylase subunits.[1]
The dodecahedral catalytic core structure made up of 60 dihydrolipoyl transacetylase subunits from Geobacillus stearothermophilus.[4]

Cube

The cubic core structure, found in species such as Azotobacter vinelandii, is made up of 24 subunits total.[5][6] The catalytic domains are assembled into trimers with the active site located at the subunit interface. The topology of this trimer active site is identical to that of chloramphenicol acetyltransferase. Eight of these trimers are then arranged into a hollow truncated cube. The two main substrates, CoA and the lipoamide (Lip(SH)2), are found at two opposite entrances of a 30 Å long channel which runs between the subunits and forms the catalytic center. CoA enters from the inside of the cube, and the lipoamide enters from the outside.[7]

Dodecahedron

In many species, including bacteria such as Geobacillus stearothermophilus and Enterococcus faecalis [4] as well as mammals such as humans[8] and cows,[9] the dodecahedral core structure is made up of 60 subunits total. The subunits are arranged in sets of three, similar to the trimers in the cubic core shape, with each set making up one of the 20 dodecahedral vertices.

Mechanism

Pyruvate decarboxylation requires a few cofactors in addition to the enzymes that make up the complex. The first is thiamine pyrophosphate (TPP), which is used by pyruvate dehydrogenase to oxidize pyruvate and to form a hydroxyethyl-TPP intermediate. This intermediate is taken up by dihydrolipoyl transacetylase and reacted with a second lipoamide cofactor to generate an acetyl-dihydrolipoyl intermediate, releasing TPP in the process. This second intermediate can then be attacked by the nucleophilic sulfur attached to Coenzyme A, and the dihydrolipoamide is released. This results in the production of acetyl CoA, which is the end goal of pyruvate decarboxylation. The dihydrolipoamide is taken up by dihydrolipoyl dehydrogenase, and with the additional cofactors FAD and NAD+, regenerates the original lipoamide (with NADH as a useful side product).

Mechanism for dihydrolipoyl transacetylase.

Biological function and location

As mentioned above, dihydrolipoyl transacetylase participates in the pyruvate decarboxylation reaction that links glycolysis to the citric acid cycle. These metabolic processes are important for cellular respiration—the conversion of biochemical energy from nutrients into adenosine triphosphate (ATP) which can then be used to carry out numerous biological reactions within a cell. The various parts of cellular respiration take place in different parts of the cell. In eukaryotes, glycolysis occurs in the cytoplasm, pyruvate decarboxylation in the mitochondria, the citric acid cycle within the mitochondrial matrix, and oxidative phosphorylation via the electron transport chain on the mitochondrial cristae. Thus pyruvate dehydrogenase complexes (containing the dihydrolipoyl transacetylase enzymes) are found in the mitochondria of eukaryotes (and simply in the cytosol of prokaryotes).

Disease relevance

Primary biliary cirrhosis

Primary biliary cirrhosis (PBC) is an autoimmune disease characterized by autoantibodies against mitochondrial and nuclear antigens. These are called anti-mitochondrial antibodies (AMA) and anti-nuclear antibodies (ANA), respectively. These antibodies are detectable in the sera of PBC patients and vary greatly with regards to epitope specificity from patient to patient. Of the mitochondrial antigens that can generate autoantibodiy reactivity in PBC patients, the E2 subunit of the pyruvate dehydrogenase complex, dihydrolipoyl transacetylase, is the most common epitope (other antigens include enzymes of the 2-oxoacid dehydrogenase complexes as well as the other enzymes of the pyruvate dehydrogenase complexes).[10] Recent evidence has suggested that peptides within the catalytic site may present the immunodominant epitopes recognized by the anti-PDC-E2 antibodies in PBC patients.[11] There is also evidence of anti-PDC-E2 antibodies in autoimmune hepatitis (AIH) patients.[12]

Pyruvate dehydrogenase deficiency

Pyruvate dehydrogenase deficiency (PDH) is a genetic disease resulting in lactic acidosis as well as neurological dysfunction in infancy and early childhood. Typically PDH is the result of a mutation in the X-linked gene for the E1 subunit of the pyruvate dehydrogenase complex. However, there have been a few rare cases in which a patient with PDH actually has a mutation in the autosomal gene for the E2 subunit instead. These patients have been reported to have much less severe symptoms, with the most prominent disease manifestation being episodic dystonia, though both hypotonia and ataxia were also present.[13]

Interactive pathway map

Click on genes, proteins and metabolites below to link to respective articles.[14]

[[File:
TCACycle_WP78 Go to article Go to article Go to article Go to article search for article Go to article Go to article go to article Go to article search for article go to article Go to article go to article Go to article Go to article go to article go to article Go to article go to article go to article go to article Go to article Go to article go to article go to article Go to article Go to article go to article go to article go to article go to article Go to article Go to article Go to article Go to article Go to article Go to article Go to article Go to article Go to article Go to article Go to article Go to article go to article
[[ ]]
[[ ]]
[[ ]]
[[ ]]
[[ ]]
[[ ]]
[[ ]]
[[ ]]
[[ ]]
[[ ]]
[[ ]]
[[ ]]
[[ ]]
[[ ]]
[[ ]]
[[ ]]
[[ ]]
[[ ]]
[[ ]]
[[ ]]
[[ ]]
[[ ]]
[[ ]]
[[ ]]
[[ ]]
[[ ]]
[[ ]]
[[ ]]
[[ ]]
[[ ]]
[[ ]]
[[ ]]
[[ ]]
[[ ]]
[[ ]]
[[ ]]
[[ ]]
[[ ]]
[[ ]]
[[ ]]
[[ ]]
[[ ]]
[[ ]]
[[ ]]
[[ ]]
TCACycle_WP78 Go to article Go to article Go to article Go to article search for article Go to article Go to article go to article Go to article search for article go to article Go to article go to article Go to article Go to article go to article go to article Go to article go to article go to article go to article Go to article Go to article go to article go to article Go to article Go to article go to article go to article go to article go to article Go to article Go to article Go to article Go to article Go to article Go to article Go to article Go to article Go to article Go to article Go to article Go to article go to article
|{{{bSize}}}px]]
Citric_acid_cycle edit

References

  1. ^ a b PDB 1EAF; Mattevi A, Obmolova G, Kalk KH, Teplyakov A, Hol WG (April 1993). "Crystallographic analysis of substrate binding and catalysis in dihydrolipoyl transacetylase (E2p)". Biochemistry 32 (15): 3887–901. doi:10.1021/bi00066a007. PMID 8471601. 
  2. ^ PDB 1Y8O; Kato M, Chuang JL, Tso SC, Wynn RM, Chuang DT (May 2005). "Crystal structure of pyruvate dehydrogenase kinase 3 bound to lipoyl domain 2 of human pyruvate dehydrogenase complex". EMBO J. 24 (10): 1763–74. doi:10.1038/sj.emboj.7600663. PMC 1142596. PMID 15861126. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1142596. 
  3. ^ Leung PS, Watanabe Y, Munoz S, Teuber SS, Patel MS, Korenberg JR, Hara P, Coppel R, Gershwin ME (1993). "Chromosome localization and RFLP analysis of PDC-E2: the major autoantigen of primary biliary cirrhosis". Autoimmunity 14 (4): 335–40. doi:10.3109/08916939309079237. PMID 8102256. 
  4. ^ a b c Izard T, Aevarsson A, Allen MD, et al. (February 1999). "Principles of quasi-equivalence and Euclidean geometry govern the assembly of cubic and dodecahedral cores of pyruvate dehydrogenase complexes". Proceedings of the National Academy of Sciences of the United States of America 96 (4): 1240–5. Bibcode 1999PNAS...96.1240I. doi:10.1073/pnas.96.4.1240. PMC 15447. PMID 9990008. http://www.pnas.org/cgi/pmidlookup?view=long&pmid=9990008. 
  5. ^ de Kok A, Hengeveld AF, Martin A, Westphal AH (June 1998). "The pyruvate dehydrogenase multi-enzyme complex from Gram-negative bacteria". Biochimica et Biophysica Acta 1385 (2): 353–66. PMID 9655933. 
  6. ^ Hanemaaijer R, Westphal AH, Van Der Heiden T, De Kok A, Veeger C (February 1989). "The quaternary structure of the dihydrolipoyl transacetylase component of the pyruvate dehydrogenase complex from Azotobacter vinelandii. A reconsideration". European Journal of Biochemistry / FEBS 179 (2): 287–92. doi:10.1111/j.1432-1033.1989.tb14553.x. PMID 2917567. http://www3.interscience.wiley.com/resolve/openurl?genre=article&sid=nlm:pubmed&issn=0014-2956&date=1989&volume=179&issue=2&spage=287. 
  7. ^ Mattevi A, Obmolova G, Schulze E, et al. (March 1992). "Atomic structure of the cubic core of the pyruvate dehydrogenase multienzyme complex". Science 255 (5051): 1544–50. Bibcode 1992Sci...255.1544M. doi:10.1126/science.1549782. PMID 1549782. http://www.sciencemag.org/cgi/pmidlookup?view=long&pmid=1549782. 
  8. ^ Brautigam CA, Wynn RM, Chuang JL, Chuang DT (May 2009). "Subunit and catalytic component stoichiometries of an in vitro reconstituted human pyruvate dehydrogenase complex". The Journal of Biological Chemistry 284 (19): 13086–98. doi:10.1074/jbc.M806563200. PMC 2676041. PMID 19240034. http://www.jbc.org/cgi/pmidlookup?view=long&pmid=19240034. 
  9. ^ Zhou ZH, McCarthy DB, O'Connor CM, Reed LJ, Stoops JK (December 2001). "The remarkable structural and functional organization of the eukaryotic pyruvate dehydrogenase complexes". Proceedings of the National Academy of Sciences of the United States of America 98 (26): 14802–7. Bibcode 2001PNAS...9814802Z. doi:10.1073/pnas.011597698. PMC 64939. PMID 11752427. http://www.pnas.org/cgi/pmidlookup?view=long&pmid=11752427. 
  10. ^ Mackay IR, Whittingham S, Fida S, et al. (April 2000). "The peculiar autoimmunity of primary biliary cirrhosis". Immunological Reviews 174: 226–37. doi:10.1034/j.1600-0528.2002.017410.x. PMID 10807519. http://www3.interscience.wiley.com/resolve/openurl?genre=article&sid=nlm:pubmed&issn=0105-2896&date=2000&volume=174&spage=226. 
  11. ^ Braun S, Berg C, Buck S, Gregor M, Klein R (February 2010). "Catalytic domain of PDC-E2 contains epitopes recognized by antimitochondrial antibodies in primary biliary cirrhosis". World Journal of Gastroenterology : WJG 16 (8): 973–81. doi:10.3748/wjg.v16.i8.973. PMC 2828602. PMID 20180236. http://www.wjgnet.com/1007-9327/16/973.asp. 
  12. ^ O'Brien C, Joshi S, Feld JJ, Guindi M, Dienes HP, Heathcote EJ (August 2008). "Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis". Hepatology (Baltimore, Md.) 48 (2): 550–6. doi:10.1002/hep.22380. PMID 18666262. 
  13. ^ Head RA, Brown RM, Zolkipli Z, et al. (August 2005). "Clinical and genetic spectrum of pyruvate dehydrogenase deficiency: dihydrolipoamide acetyltransferase (E2) deficiency". Annals of Neurology 58 (2): 234–41. doi:10.1002/ana.20550. PMID 16049940. 
  14. ^ The interactive pathway map can be edited at WikiPathways: "TCACycle_WP78". http://www.wikipathways.org/index.php/Pathway:WP78. 

Further reading

External links


Wikimedia Foundation. 2010.

Игры ⚽ Поможем написать курсовую

Look at other dictionaries:

  • Dihydrolipoyl-Transacetylase — Masse/Länge Primärstruktur 561 Aminosäuren …   Deutsch Wikipedia

  • dihydrolipoyl transacetylase — di·hy·dro·lip·o·yl trans·acet·y·lase (di hi″dro lipґo əl trans″ə setґə lās) dihydrolipoyllysine residue acetyltransferase …   Medical dictionary

  • Dihydrolipoyl-Transsuccinylase — Masse/Länge Primärstruktur 453 Aminosäuren …   Deutsch Wikipedia

  • Dihydrolipoyl-Transacylase — Masse/Länge Primärstruktur 421 Aminosäuren …   Deutsch Wikipedia

  • Dihydrolipoyl déshydrogénase — Structure d une E3 humaine (PDB 1ZY8) …   Wikipédia en Français

  • Pyruvate dehydrogenase complex — (PDC) is a complex of three enzymes that transform pyruvate into acetyl CoA by a process called pyruvate decarboxylation. Acetyl CoA may then be used in the citric acid cycle to carry out cellular respiration, and this complex links the… …   Wikipedia

  • Dihydrolipoamide S-acétyltransférase — Acétyl CoA:dihydrolipoamide S acétyltransférase (E2) Structure d une sous unité de dihydrolipoamide S acét …   Wikipédia en Français

  • Pyruvatdehydrogenase-Komplex — Übergeordnet Zytosol Gene Ontology …   Deutsch Wikipedia

  • PDHA1 — Pyruvate dehydrogenase (lipoamide) alpha 1, also known as PDHA1, is a human gene. PBB Summary section title = summary text = The pyruvate dehydrogenase complex is a nuclear encoded mitochondrial matrix multienzyme complex that provides the… …   Wikipedia

  • Compartment (chemistry) — In chemistry, a compartment is a part of a protein that serves a specific function. There may be multiple compartments on one and the same protein. One example is the case of Pyruvate dehydrogenase complex. This is the enzyme which catalyses… …   Wikipedia

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”